Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

Being too fat or too thin 'can cost four years of life'
Being too fat or too thin 'can cost four years of life'
Being overweight or underweight could knock four years off life expectancy, a study in a Lancet journal suggests.
116 Countries, 859 Arrests; Interpol Makes A Grand Seizure Of 500 Tonnes
116 Countries, 859 Arrests; Interpol Makes A Grand Seizure Of 500 Tonnes
A total of 859 people were arrested while approximately 1,000,000 packages were screenedCoordinated police raids in 116 countries have netted 500 tonnes of illicit pharmaceuticals available online, in...
Pfizer Is Weighing Sale of $2 Billion-Women's Health Portfolio
Pfizer Is Weighing Sale of $2 Billion-Women's Health Portfolio
Pfizer Inc.
Long-term prognosis of Chagas patients improved with anti-parasite drug
Long-term prognosis of Chagas patients improved with anti-parasite drug
Researchers have found that the anti-parasite drug benznidazole may improve the long-term prognoses of patients with chronic Chagas disease, according to a study published in PLOS Neglected Tropical D...
How salt can trigger inflammation in multiple sclerosis
How salt can trigger inflammation in multiple sclerosis
Researchers at Yale have identified a high-salt environment as one of the contributing factors to the development of multiple sclerosis (MS).
Green light for Roche’s chemo-free CLL treatment combo
Green light for Roche’s chemo-free CLL treatment combo
Roche says a combination of Venclyxto and MabThera has been approved in the European Union for people with previously treated chronic lymphocytic leukaemia.
EU approves Vertex’ cystic fibrosis combo
EU approves Vertex’ cystic fibrosis combo
The European Commission has approved Vertex’ Symveki in a combination regimen with Kalydeco to treat certain patients with cystic fibrosis (CF).
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
KENILWORTH, N.
ViiV Healthcare reports positive 48-week results for second phase III study for novel, long-acting, injectable HIV-treatment regimen
ViiV Healthcare reports positive 48-week results for second phase III study for novel, long-acting, injectable HIV-treatment regimen
ViiV Healthcare today announced positive headline results from its global, Phase III FLAIR (First Long-Acting Injectable Regimen) study of a long-acting, injectable two-drug regimen (2DR&#...
Drugmakers tout new medicines as eye disease battle intensifies
Drugmakers tout new medicines as eye disease battle intensifies
ZURICH (Reuters) - Switzerland’s Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as patent expiries are...
More than 90% of the world’s children breathe toxic air every day
More than 90% of the world’s children breathe toxic air every day
Every day around 93% of the world’s children under the age of 15 years (1.
Long-lasting HIV injection is a step closer after second GSK study
Long-lasting HIV injection is a step closer after second GSK study
LONDON (Reuters) - A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for s...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand